Manoj Nerurkar's Biography

Manoj Nerurkar, Chief Operating Officer, Syngene International

Dr. Manoj Nerurkar is the Chief Operating Officer of Syngene since April 2012. He joined Syngene in 2009 to head the Formulation Development Center, and was the Vice President & Head - Small Molecule Discovery & Development till March 2012.As the head of the senior leadership team of scientific department, business development and project management, Manoj has been instrumental in terms of both strategic leadership and operational management in underpinning Syngene's recent growth and evolution. He is also responsible for implementing the strategies for growth and enabling operational excellence across Syngene. He identifies and builds new business opportunities to maintain the company's market leadership position and profitability. He is working with the Syngene Board of Directors to bring future opportunities to fruition through adequate investment in new infrastructure and technologies. Manoj has extensive experience in the development of oral solid & injectable dosage forms from Phase I to commercialization. Prior to joining Syngene, Manoj worked for Novartis and was responsible for setting up their Drug Development R&D center in India. Manoj has also worked with Bristol-Myers Squibb in New Jersey, for 12 years, where he had the opportunity to work on the development of various dosage forms including immediate and modified release tablets, capsules, and conventional and depot injectable formulations of small and biological molecules. He has two commercial products to his credit which include an intravenous formulation of BMS' first biologic molecule - Orencia and an intramuscular formulation of an anti-schizophrenic drug - Abilify. Manoj obtained his PhD in Pharmaceutical Chemistry from University of Kansas, and Management Degree from the Wharton School of Business, USA. He holds several patents in the Formulation Development area and has several publications to his credit in international peer-reviewed journals.